News and Insights
From the Medical Affairs Experts at Zipher
Lumanity Acquires Innovation Edge
Lumanity acquires Innovation Edge, creating an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances.
The Importance of Cross-Functional Integration
Are you challenged by siloed structures within your Medical Affairs organization? Our latest blog, by Julie Cahill, MD, V.P., Consulting and Medical Director Services, captures the essence and importance of cross-functional integration within Medical Affairs organizations.
Introducing Lumanity
Lumanity brings together a diverse collection of expert perspectives to uncover innovative yet pragmatic approaches to address the diverse and complex set of challenges associated with bringing medical advances to patients.
Medical Affairs Capabilities to Create a Competitive Advantage – Podcast Episode 10
Our host Peg Crowley-Nowick and guest Tamas Suto, Head of Global MA Oncology at Merck KGaA, Darmstadt, Germany, discuss how leading Medical Affairs (MA) organizations have begun to strategically redefine their team’s requisite executional capabilities to enhance and tailor frontline engagement initiatives.
The Importance of Team Engagement
Partnering with an Alliance and aligning your medical strategy can be a daunting task. Zipher’s own Julie Cahill, MD outlines a unique approach for developing a concise medical strategy that drives impact and demonstrates value.
Arsenal’s Value Demonstration Business Acquires Zipher Medical Affairs
Arsenal Capital Partners, a private equity firm specializing in building healthcare businesses, today announced the acquisition of Zipher Medical Affairs, a leading provider of expert medical affairs strategic consulting services in the United States.
Fostering Data Generation to Build the Value Story
A well-planned and comprehensive data generation program will provide you with the tools you need to be successful in preparing for launch and beyond.
The Value of Insights
Insights provide the ability to gain a clear, deep, and sometimes unexpected understanding of a complicated problem or situation. In the pharmaceutical arena, insights are external trends that are actionable and have the potential to alter medical strategy
Gathering, Understanding, and Leveraging Insights – Podcast Episode 9
Host Peg Crowley-Nowick, PhD, MBA, Founder & President of Zipher Medical Affairs and Murial Siadak, PAC, spotlight the ever-increasing value and impact of insights on product strategy, positioning, and tactics.
Five Things to Consider for Effective PM Tracking Systems
An effective program management system with well-designed project trackers, dashboards and project management support can accelerate your launch strategy.
Medical Affairs Launch Readiness: Building, Planning & Execution – Podcast Episode 8
Drs. Crowley-Nowick and Keir set the stage for a successful launch as they consider the key components of a MA Team and their contributions on the road to launch and beyond, from the formation and training of the Medical Science Liaison Team (MSLs) to the early inclusion of Medical Information, to developing best practices for Scientific Communications while also engaging with Patient Advocacy groups as part of the planning process.
Executing Launch: Develop, Visualize, and Communicate – Podcast Episode 7
Starting from the clinical trials and ending with meeting the regulatory demands across various countries, bringing a product to market successfully has become increasingly difficult. Therefore, it is critical that an overall launch strategy is established and executed.
